Agency Information Collection Activities: Proposed Collection; Comment Request, 8798-8799 [E9-3959]
Download as PDF
8798
Federal Register / Vol. 74, No. 37 / Thursday, February 26, 2009 / Notices
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: February 17, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–3958 Filed 2–25–09; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION:
Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Understanding Patients’ Knowledge
and Use of Acetaminophen.’’ In
accordance with the Paperwork
Reduction Act of 1995, 44 U.S.C.
3506(c)(2)(A), AHRQ invites the public
to comment on this proposed
information collection.
DATES: Comments on this notice must be
received by April 27, 2009.
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@ahrq.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
16:56 Feb 25, 2009
Jkt 217001
Proposed Project
‘‘Understanding Patients’ Knowledge
and Use of Acetaminophen’’
This proposed data collection is a
qualitative study to preliminarily
identify issues that relate to the misuse
and overdosing of over-the-counter
(OTC) acetaminophen. Toxicity from
acetaminophen has been on the rise in
the past 3 decades, and is now the most
common cause of acute liver failure in
the U.S., surpassing viral hepatitis. This
data collection has two aims. Aim 1 is
to qualitatively explore knowledge,
attitudes, beliefs, and practices
regarding adult and adolescent selfadministration of OTC acetaminophen,
and parental administration of OTC
acetaminophen to children. To meet
Aim 1, focus groups will be conducted
with adults and semi-structured
interviews will be conducted with
adolescents. Aim 2 is to qualitatively
explore experiences and practices of key
professional informants, including
physicians and pharmacists, with
respect to communicating information
on the administration and risks of OTC
acetaminophen to consumers and
patients. Semi-structured interviews
will be conducted with target key
informants. The results of this
qualitative study will provide an
understanding of the relevant issues and
will be used to develop a
comprehensive survey. A second OMB
clearance package will be developed
once the questionnaire for the survey is
available.
This project is being funded by AHRQ
pursuant to a cooperative agreement
with the University of Pennsylvania
(Award 1 U18HS017991) as part of the
Centers for Education and Research on
Therapeutics (CERTs) program. The
CERTs program is a national initiative,
administered by AHRQ in consultation
with the Food and Drug Administration,
to increase awareness of the benefits
and risks of new, existing, or combined
uses of therapeutics through education
and research. See 42 U.S.C. 299b–1(b).
Method of Collection
Aim 1—Focus groups and individual
interviews
Four focus groups will be conducted
with parents of young children to
examine administration of
acetaminophen to children. Four focus
groups will also be conducted with
adults to identify the issues, barriers,
and psychosocial factors surrounding
how, when, and why OTC
acetaminophen is used. Focus groups
will each have 6 to 8 participants. Semistructured interviews will be conducted
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
with adolescents to examine selfadministration of acetaminophen among
this group.
Content areas to be explored are: a.
Knowledge about acetaminophen:
Brands, terms, combinations, dosage,
administration, indications; b. beliefs
about benefits and risks, including
thresholds for toxicity and death; c.
patterns and frequency of use; d.
sources of information (e.g., physicians,
pharmacists, media); e. related
experiences in peers (e.g., advice,
reports of toxicity); and f. views about
labeling, packaging and legislation (e.g.,
restrictions in sales).
Aim 2—Semi-structured interviews with
physicians and pharmacists
Twenty primary care physicians and
20 pharmacists will be interviewed.
Primary care physicians will be
recruited through a primary care
research network of physicians from
both private and public clinics.
Pharmacists will be recruited at
pharmacy facilities from hospitals and
clinics. Interviews will be conducted
over the phone or in person, according
to the participant’s preference, and will
last approximately 20 minutes. All
interviews will be audio-taped and
transcribed. Participants will be asked
about the following: a. Frequency and
patterns of interaction with consumers
and patients with respect to
acetaminophen; b. types of information
provided to consumers; c. availability of
education materials; and d. views about
labeling, packaging and legislation.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents’ time to participate in this
project. The screening form will be
completed by all participants and is
expected to take approximately 3
minutes to complete. Focus groups will
include 2 populations: Parents of
children 8 years of age and adults, and
will last about 11⁄2 hours. Semistructured interviews will be conducted
with 20 adolescents, 20 primary care
physicians, and 20 pharmacists and will
last 20 to 30 minutes. The selfadministered questionnaire will be
completed by the focus group
participants and the adolescent
participants of the semi-structured
interviews, and will take about 6
minutes to complete. The total burden
for all participants is estimated to be
134 hours.
Exhibit 2 shows the estimated
annualized cost burden for the
respondent’s time to participate in the
project. The total cost is estimated to be
$2,001.
E:\FR\FM\26FEN1.SGM
26FEN1
8799
Federal Register / Vol. 74, No. 37 / Thursday, February 26, 2009 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Data collection mode
Hours per
response
Total burden
hours
Screening form ................................................................................
Self-administered questionnaire ......................................................
Focus group with parents of children <8 years of age (4 groups of
8 participants) ...............................................................................
Focus group with adults (4 groups of 8 participants) ......................
Semi-structured interviews with adolescents (13 to 20 years of
age) ..............................................................................................
Semi-structured interviews with primary care physicians ................
Semi-structured interviews with pharmacists ..................................
124
84
1
1
3/60
6/60
6
8
32
32
1
1
1.5
1.5
48
48
20
20
20
1
1
1
30/60
20/60
20/60
10
7
7
Total ..........................................................................................
332
............................
............................
134
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Data collection mode
Total burden
hours
Average hourly
wage rate*
Total cost burden
Screening form ................................................................................
Self-administered questionnaire ......................................................
Focus groups with parents of children <8 years of age (4 groups
of 8 participants) ..........................................................................
Focus groups with adults (4 groups of 8 participants) ....................
Semi-structured interviews with adolescents (13 to 20 years of
age) ..............................................................................................
Semi-structured interviews with primary care physicians ................
Semi-structured interviews with pharmacists ..................................
124
84
6
8
$10.30
10.30
$62
82
32
32
48
48
10.30
10.30
494
494
20
20
20
10
7
7
10.30
61.10
48.22
103
428
338
Total ..........................................................................................
332
134
............................
2,001
* Patient average hourly wage based on the average per capita income of $21,435 (computed into an hourly wage rate of $10.30) in Harris
County, Texas where the study will take place. Provider hourly wage based on the following estimates from National Compensation Survey: Occupational wages in the United States 2006, U.S. Department of Labor, Bureau of Labor Statistics: Primary care physician = $61.10/hour; pharmacist = $48.22/hour.
Estimates of Annualized Cost to the
Government
Exhibit 3 shows the estimated cost to
the Federal Government for this six
month project.
The total cost is $164,440. This
amount includes all direct and indirect
costs of the design, data collection,
analysis, and reporting phase of the
study.
EXHIBIT 3—ESTIMATED COST
Cost component
Total cost
Project Development ................
Data Collection Activities ..........
Data Processing and Analysis
Publication of Results ...............
Project Management ................
Overhead ..................................
$13,250
61,699
14,080
750
17,000
57,661
Total ...................................
164,440
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
VerDate Nov<24>2008
16:56 Feb 25, 2009
Jkt 217001
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: February 17, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–3959 Filed 2–25–09; 8:45 am]
BILLING CODE 4160–90–M
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0631]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Medical Device
Recall Authority
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by March 30,
2009.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
E:\FR\FM\26FEN1.SGM
26FEN1
Agencies
[Federal Register Volume 74, Number 37 (Thursday, February 26, 2009)]
[Notices]
[Pages 8798-8799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Understanding Patients' Knowledge and Use of
Acetaminophen.'' In accordance with the Paperwork Reduction Act of
1995, 44 U.S.C. 3506(c)(2)(A), AHRQ invites the public to comment on
this proposed information collection.
DATES: Comments on this notice must be received by April 27, 2009.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by e-mail at
doris.lefkowitz@ahrq.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by e-mail at
doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
``Understanding Patients' Knowledge and Use of Acetaminophen''
This proposed data collection is a qualitative study to
preliminarily identify issues that relate to the misuse and overdosing
of over-the-counter (OTC) acetaminophen. Toxicity from acetaminophen
has been on the rise in the past 3 decades, and is now the most common
cause of acute liver failure in the U.S., surpassing viral hepatitis.
This data collection has two aims. Aim 1 is to qualitatively explore
knowledge, attitudes, beliefs, and practices regarding adult and
adolescent self-administration of OTC acetaminophen, and parental
administration of OTC acetaminophen to children. To meet Aim 1, focus
groups will be conducted with adults and semi-structured interviews
will be conducted with adolescents. Aim 2 is to qualitatively explore
experiences and practices of key professional informants, including
physicians and pharmacists, with respect to communicating information
on the administration and risks of OTC acetaminophen to consumers and
patients. Semi-structured interviews will be conducted with target key
informants. The results of this qualitative study will provide an
understanding of the relevant issues and will be used to develop a
comprehensive survey. A second OMB clearance package will be developed
once the questionnaire for the survey is available.
This project is being funded by AHRQ pursuant to a cooperative
agreement with the University of Pennsylvania (Award 1 U18HS017991) as
part of the Centers for Education and Research on Therapeutics (CERTs)
program. The CERTs program is a national initiative, administered by
AHRQ in consultation with the Food and Drug Administration, to increase
awareness of the benefits and risks of new, existing, or combined uses
of therapeutics through education and research. See 42 U.S.C. 299b-
1(b).
Method of Collection
Aim 1--Focus groups and individual interviews
Four focus groups will be conducted with parents of young children
to examine administration of acetaminophen to children. Four focus
groups will also be conducted with adults to identify the issues,
barriers, and psychosocial factors surrounding how, when, and why OTC
acetaminophen is used. Focus groups will each have 6 to 8 participants.
Semi-structured interviews will be conducted with adolescents to
examine self-administration of acetaminophen among this group.
Content areas to be explored are: a. Knowledge about acetaminophen:
Brands, terms, combinations, dosage, administration, indications; b.
beliefs about benefits and risks, including thresholds for toxicity and
death; c. patterns and frequency of use; d. sources of information
(e.g., physicians, pharmacists, media); e. related experiences in peers
(e.g., advice, reports of toxicity); and f. views about labeling,
packaging and legislation (e.g., restrictions in sales).
Aim 2--Semi-structured interviews with physicians and pharmacists
Twenty primary care physicians and 20 pharmacists will be
interviewed. Primary care physicians will be recruited through a
primary care research network of physicians from both private and
public clinics. Pharmacists will be recruited at pharmacy facilities
from hospitals and clinics. Interviews will be conducted over the phone
or in person, according to the participant's preference, and will last
approximately 20 minutes. All interviews will be audio-taped and
transcribed. Participants will be asked about the following: a.
Frequency and patterns of interaction with consumers and patients with
respect to acetaminophen; b. types of information provided to
consumers; c. availability of education materials; and d. views about
labeling, packaging and legislation.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents' time to participate in this project. The screening form
will be completed by all participants and is expected to take
approximately 3 minutes to complete. Focus groups will include 2
populations: Parents of children 8 years of age and adults, and will
last about 1\1/2\ hours. Semi-structured interviews will be conducted
with 20 adolescents, 20 primary care physicians, and 20 pharmacists and
will last 20 to 30 minutes. The self-administered questionnaire will be
completed by the focus group participants and the adolescent
participants of the semi-structured interviews, and will take about 6
minutes to complete. The total burden for all participants is estimated
to be 134 hours.
Exhibit 2 shows the estimated annualized cost burden for the
respondent's time to participate in the project. The total cost is
estimated to be $2,001.
[[Page 8799]]
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Data collection mode Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Screening form.......................... 124 1 3/60 6
Self-administered questionnaire......... 84 1 6/60 8
Focus group with parents of children <8 32 1 1.5 48
years of age (4 groups of 8
participants)..........................
Focus group with adults (4 groups of 8 32 1 1.5 48
participants)..........................
Semi-structured interviews with 20 1 30/60 10
adolescents (13 to 20 years of age)....
Semi-structured interviews with primary 20 1 20/60 7
care physicians........................
Semi-structured interviews with 20 1 20/60 7
pharmacists............................
-----------------------------------------------------------------------
Total............................... 332 ................ ................ 134
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Data collection mode respondents hours wage rate* burden
----------------------------------------------------------------------------------------------------------------
Screening form.......................... 124 6 $10.30 $62
Self-administered questionnaire......... 84 8 10.30 82
Focus groups with parents of children <8 32 48 10.30 494
years of age (4 groups of 8
participants)..........................
Focus groups with adults (4 groups of 8 32 48 10.30 494
participants)..........................
Semi-structured interviews with 20 10 10.30 103
adolescents (13 to 20 years of age)....
Semi-structured interviews with primary 20 7 61.10 428
care physicians........................
Semi-structured interviews with 20 7 48.22 338
pharmacists............................
-----------------------------------------------------------------------
Total............................... 332 134 ................ 2,001
----------------------------------------------------------------------------------------------------------------
* Patient average hourly wage based on the average per capita income of $21,435 (computed into an hourly wage
rate of $10.30) in Harris County, Texas where the study will take place. Provider hourly wage based on the
following estimates from National Compensation Survey: Occupational wages in the United States 2006, U.S.
Department of Labor, Bureau of Labor Statistics: Primary care physician = $61.10/hour; pharmacist = $48.22/
hour.
Estimates of Annualized Cost to the Government
Exhibit 3 shows the estimated cost to the Federal Government for
this six month project.
The total cost is $164,440. This amount includes all direct and
indirect costs of the design, data collection, analysis, and reporting
phase of the study.
Exhibit 3--Estimated Cost
------------------------------------------------------------------------
Cost component Total cost
------------------------------------------------------------------------
Project Development........................................ $13,250
Data Collection Activities................................. 61,699
Data Processing and Analysis............................... 14,080
Publication of Results..................................... 750
Project Management......................................... 17,000
Overhead................................................... 57,661
------------
Total.................................................. 164,440
------------------------------------------------------------------------
Request for Comments
In accordance with the above-cited Paperwork Reduction Act
legislation, comments on AHRQ's information collection are requested
with regard to any of the following: (a) Whether the proposed
collection of information is necessary for the proper performance of
AHRQ health care research, quality improvement and information
dissemination functions, including whether the information will have
practical utility; (b) the accuracy of AHRQ's estimate of burden
(including hours and costs) of the proposed collection(s) of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; and (d) ways to minimize the burden of
the collection of information upon the respondents, including the use
of automated collection techniques or other forms of information
technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: February 17, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-3959 Filed 2-25-09; 8:45 am]
BILLING CODE 4160-90-M